Table 1 Baseline characteristics of the study population
Clinical characteristics | Overall population | Non-survivors | Survivors | P- value |
|---|---|---|---|---|
(n = 1148) | (n = 138) | (n = 1010) | ||
Age, years | 67.2 ± 6.9 | 70.9 ± 6.9 | 66.7 ± 6.8 | < 0.001 |
Male | 654 (57.0) | 82 (59.4) | 572 (56.6) | 0.535 |
BMI, kg/m2 | 25.4 ± 2.8 | 25.7 ± 2.8 | 25.4 ± 2.8 | 0.321 |
Duration of diabetes, years | 10.0(4.0–15.0) | 9.5(4.8–14.3) | 10.0 (4.0–15.0) | 0.780 |
Smoker | 471 (41.0) | 68 (49.3) | 403 (39.9) | 0.036 |
Hypertension | 934 (81.4) | 123 (89.1) | 811 (80.3) | 0.012 |
Family history of CAD | 118 (10.3) | 14 (10.1) | 104 (10.3) | 0.956 |
Previous MI | 176 (15.3) | 31 (22.5) | 145 (14.4) | 0.013 |
Previous PCI | 245 (21.3) | 26 (18.8) | 219 (21.6) | 0.445 |
Previous CABG | 68 (5.9) | 10 (7.2) | 58 (5.7) | 0.483 |
Previous stroke | 294 (25.6) | 47 (34.1) | 247 (24.5) | 0.015 |
Clinical presentation | 0.195 | |||
SAP | 293(25.5) | 29(21.0) | 264 (26.1) | |
ACS | 855(74.5) | 109(79.0) | 746 (73.9) | |
LVEF | 58(52–62) | 56(45–60) | 58 (54–62) | < 0.001 |
Laboratory findings | ||||
Hemoglobin, g/dl | 131.0 ± 18.9 | 126.9 ± 19.7 | 131.5.1 ± 18.7 | 0.007 |
FPG, mmol/L | 8.0 ± 3.1 | 9.4 ± 3.8 | 7.8 ± 2.9 | < 0.001 |
HbA1c, % | 7.7 ± 1.4 | 7.8 ± 1.4 | 7.7 ± 1.5 | 0.559 |
SHR | 0.87 ± 0.40 | 1.02 ± 0.48 | 0.85 ± 0.38 | < 0.001 |
TC, mmol/L | 4.48 ± 1.20 | 4.29 ± 1.10 | 4.51 ± 1.21 | 0.041 |
TG, mmol/L | 1.54(1.14–2.08) | 1.35(1.06–1.90) | 1.56(1.15–2.11) | 0.014 |
HDL-C, mmol/L | 1.03 ± 0.29 | 0.99 ± 0.27 | 1.04 ± 0.29 | 0.089 |
LDL-C, mmol/L | 2.98 ± 1.00 | 2.84 ± 0.93 | 3.00 ± 1.02 | 0.084 |
hs-CRP, mg/L | 2.16(0.82–5.96) | 3.82(0.94–13.50) | 2.03(0.81–5.38) | 0.001 |
NT-proBNP, pg/ml Creatinine(umol/l) | 232.0 (97.6–895.1) | 839.8 (230.0–2414.5) | 201.1 (88.9–712.5) | < 0.001 |
< 0.001 | ||||
Three-vessel disease | 75.5 ± 27.4 | 86.3 ± 31.9 | 74.0 ± 26.4 | 0.058 |
Left main disease | 856 (74.6) | 112 (81.2) | 744 (73.7) | 0.024 |
Treatment | 154 (13.4) | 27 (19.6) | 127 (12.6) | 0.498 |
Medicine treatment | ||||
PCI | 271 (23.6) | 37 (26.8) | 234 (23.2) | |
CABG | 701 (61.1) | 78 (56.5) | 623 (61.7) | |
Medications at discharge | 176 (15.3) | 23 (16.7) | 153 (15.1) | |
Aspirin | 0.120 | |||
Clopidogrel/Ticagrelor | 1117 (97.3) | 131 (94.9) | 986 (97.6) | 0.896 |
β-blocker | 1011 (88.1) | 122 (88.4) | 889 (88.0) | 0.864 |
ACEI/ARB | 781 (68.0) | 93 (67.4) | 688 (68.1) | 0.625 |
Statin | 660 (57.5) | 82 (59.4) | 578 (57.2) | 0.018 |
Insulin | 1100 (95.8) | 127 (92.0) | 973 (96.3) | 0.689 |
481 (41.9) | 60 (43.5) | 421 (41.7) | ||